SCHEMBL4555211

SCHEMBL4555211

Cc1cc(-c2ccncc2NC(=O)c2nc(Br)c(F)cc2N)nc(NC(=O)O)n1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM2 Q9P1W9 20/20 0.50
PIM1 P11309 17/20 0.48
PIM3 Q86V86 17/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434950 0.89 PIM2 (0.46) PIM2PIM1PIM3
SCHEMBL4555208 0.84 PIM2 (0.38) PIM2PIM1PIM3
SCHEMBL4437161 0.79 PIM2 (0.44) PIM2PIM1PIM3
SCHEMBL11909095 0.73 PIM2 (0.83) PIM2PIM1PIM3
SCHEMBL16004176 0.71 PIM2 (0.51) PIM2PIM1PIM3
SCHEMBL12077496 0.70 PIM3 (0.63) PIM2PIM1PIM3
SCHEMBL11906299 0.69 PIM2 (0.71) PIM2PIM1PIM3
SCHEMBL11984296 0.69 PIM2 (0.62) PIM2PIM1PIM3
SCHEMBL11984874 0.68 PIM2 (0.62) PIM2PIM1PIM3
SCHEMBL4444624 0.67 PIM2 (0.44) PIM2PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed